IAIM
LUMO

International Assets Investment Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

International Assets Investment Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-38
Closed -$88 – 2716
2024
Q2 		$88 Buy
+38
New +$98 ﹤0.01% 2243
2021
Q2 		– Sell
-222
Closed -$8K – 1989
2021
Q1 		$8K Hold
222
– – ﹤0.01% 1658
2020
Q4 		$8K Buy
+222
New +$3.83K ﹤0.01% 1520

Other funds holding LUMO

PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

International Assets Investment Management's LUMO Position: Q3 2024 in Review

International Assets Investment Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2024, closing a stake of 38 shares — an estimated $88 sold.

International Assets Investment Management first reported a position in LUMO in Q4 2020 and held it in 3 quarters. The position peaked at $8K in Q1 2021. 28 funds tracked by Wall St. Rank hold LUMO as of Q3 2024.

  • International Assets Investment Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • International Assets Investment Management sold 38 Lumos Pharma, Inc. Common Stock shares in Q3 2024, an estimated $88.
  • International Assets Investment Management first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • International Assets Investment Management's Lumos Pharma, Inc. Common Stock position peaked at $8K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2024.

Based on International Assets Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.